Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 5, 2005. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons regarding the company's ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The material change reported is a transfer of 11,428 Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991. This transaction occurred on October 4, 2005, and was advised to the company on October 5, 2005.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust for current and former employees, and three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) hold interests in the trust shares similarly to other employees.
Key Facts for Investor Verification
- 11,428 Ordinary Shares were transferred from the GSK Trust to employee plan participants on October 4, 2005.
- Three directors have an interest in the shares held within the GSK Trust.
- This filing is a compliance notification under Disclosure Rule 3.1.4R(1)(b) and does not include financial statements.